Prasugrel CAS 150322-43-3: Advanced Antiplatelet Agent for Cardiovascular Health
Revolutionizing blood clot prevention for critical cardiovascular conditions.
Get a Quote & SampleProduct Core Value
Prasugrel
Prasugrel is a highly effective thienopyridine drug that plays a crucial role in preventing thrombotic cardiovascular events. By irreversibly inhibiting P2Y12 ADP receptors on platelets, it significantly reduces platelet aggregation. This action is vital for patients at high risk of heart attack or stroke, especially those undergoing procedures like percutaneous coronary intervention (PCI).
- Understand the Prasugrel antiplatelet mechanism and how it offers advanced protection against cardiovascular events.
- Explore the superior efficacy of Prasugrel in preventing heart attack and stroke compared to other treatments.
- Learn about the key Prasugrel drug interactions and precautions for safe usage.
- Discover the critical role of Prasugrel in Acute Coronary Syndrome management.
Product Advantages
Enhanced Platelet Inhibition
Prasugrel offers a rapid and potent inhibition of platelet aggregation, crucial for preventing blood clots. Its mechanism of action ensures reliable P2Y12 receptor blockade.
Superior Efficacy Profile
Demonstrated to be more effective than clopidogrel in reducing ischemic cardiovascular events, Prasugrel offers improved patient outcomes.
Targeted Cardiovascular Support
Specifically designed for patients undergoing PCI, Prasugrel provides targeted protection against complications like stent thrombosis, supporting overall cardiovascular health.
Key Applications
Acute Coronary Syndrome Management
Prasugrel is essential for managing Acute Coronary Syndrome, offering vital protection against thrombotic events in vulnerable patients.
Percutaneous Coronary Intervention (PCI) Support
Used in conjunction with PCI, Prasugrel significantly reduces the risk of stent thrombosis and other post-procedural complications.
Stroke and Heart Attack Prevention
The targeted action of Prasugrel makes it a key agent in the long-term prevention of strokes and heart attacks for high-risk individuals.
Pharmaceutical Research and Development
As a key active pharmaceutical ingredient, Prasugrel serves as a vital compound for ongoing research in cardiovascular therapies.